WASHINGTON - Republican legislation to cut off federal funding for Planned Parenthood failed to gather enough support in the U.S. Senate on Monday, halting at least for now moves to punish the group for its role in gathering fetal tissue from abortions for medical research.
SEOUL - Tech giant Samsung Electronics Co Ltd said on Monday it will create a 100 billion won ($85.8 million) fund to compensate cancer-stricken workers and their families, and for efforts to prevention such diseases at its chip and display factories.
(Reuters Health) - Heart attacks seem to have a bigger effect on life expectancy for women and African Americans than for white men, a new study shows.
- An influential U.S. health panel said on Monday it needs more evidence to support universal screening for autism in young children who show no developmental problems, in a departure from recommendations issued by other medical groups.
NEW YORK - Eli Lilly & Co on Tuesday will confront the first U.S. trial over allegations it failed to warn users of its popular antidepressant Cymbalta that they could suffer severe withdrawal symptoms, including suicidal thoughts and electric shock-like sensations.
(Reuters Health) - Preschoolers who are extremely picky eaters may also be more prone to mental health problems, a study suggests.
(Reuters Health) - Kids with traumatic brain injury (TBI) have more lapses in attention and longer reaction times than children who suffer trauma to other parts of the body, researchers report.
(Reuters Health) - High doses of vitamin D may not help strengthen bones in postmenopausal women, a study suggests.
- The U.S. Food and Drug Administration has, for the first time, approved a drug that uses 3D printing technology, paving the way for potential customization of drugs to suit patients' needs.
(This August 1 story has been refiled to correct the name of the company in paragraph three from Advanced Cell Technology to Ocata Therapeutics.)